Xilio Therapeutics, Inc. (XLO) Operating cash flow 2020–2025
Xilio Therapeutics, Inc. (XLO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.0MFY2025 · since FY2020: -$36.1M → -$5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.0M | +72.8% |
| FY2024 | -$18.4M | +73.2% |
| FY2023 | -$68.6M | +9.4% |
| FY2022 | -$75.7M | +6.2% |
| FY2021 | -$80.8M | -123.7% |
| FY2020 | -$36.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice